Vector Bioscience Cambridge Ltd

Startup

Vector, a University of Cambridge spin-out, is revolutionizing cancer therapy with our RNA delivery platform. Our technology protects and delivers RNA directly to the tumour, with a controlled release, mitigating side effects.